Home / Brands / Dragon Pharma / Dragon Pharma AOD 9604 5 mg hGH Fragment 176-191 Research Vial
U.S Domestic Available Domestic
Dragon Pharma AOD 9604 5 mg hGH Fragment 176-191 Research Vial
Dragon Pharma

Dragon Pharma AOD 9604 5 mg hGH Fragment 176-191 Research Vial

Injection · 5 mg · vial

In stock · ships within 24h Out of stock
$120.00

Dragon Pharma AOD 9604 is a 5 mg lyophilized vial of the growth hormone fragment 176-191, the piece of the hormone tied to fat breakdown rather than growth. Its clinical program was closed in 2007, so it is research material only.

GMP-manufactured, HPLC-verified with the Certificate of Analysis on file. AOD 9604 for sale with U.S. domestic and international shipping.

Shipping Not available in this combination
1
Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Dragon Pharma AOD 9604 5 mg Fragment Vial

AOD 9604 is the last 16 amino acids of human growth hormone, residues 176 to 191, isolated because that piece of the molecule carries the fat-mobilizing activity without the growth and blood sugar effects attributed to whole growth hormone. In research it did not raise IGF-1, which is precisely why it attracted attention. The clinical program failed, however: development stopped in 2007 after missing its endpoints, so this is a fragment with an interesting mechanism and no approved future.

  • 5 mg lyophilized powder per vial, one pack option
  • hGH fragment 176-191, 16 amino acids
  • GMP-manufactured and HPLC-verified, COA per batch
  • U.S. domestic and international shipping options

How AOD 9604 Works

The fragment mimics the lipolytic region of growth hormone, so it is studied as a signal for fat mobilization rather than for tissue growth. The honest part of the record is the trial history: a 12-week randomized study showed about 1.8 kg more weight loss than placebo, and a later 24-week study did not show sufficient lipolytic effect, after which the program was closed. No half-life is established in the sources. Unlike the secretagogues such as CJC-1295 DAC, this peptide is a fragment of the hormone itself rather than a stimulus to release it.

Reconstitution & Research Use

Add bacteriostatic water slowly down the glass wall and swirl, never shake. Five milligrams with 2 ml gives 2.5 mg/ml, so 0.1 ml holds 250 mcg and reads as 10 units on a U-100 insulin syringe; 1 ml instead of 2 doubles that to 500 mcg in the same units. Community material describes 250 to 500 mcg a day subcutaneously, often before fasted cardio, in blocks of four to twelve weeks, and frequently alongside another weight-oriented peptide such as Adipotide or the long-acting Semaglutide. Reported class effects are injection-site reactions and headache, with no frequency data for this fragment.

Quality & Authenticity

Each batch is produced under GMP conditions and checked by HPLC, with a Certificate of Analysis held for the batch. Keep the powder cold and dark and the mixed solution refrigerated.

For laboratory research only. Consult a healthcare professional before use.

Specifications

BrandDragon Pharma
Active SubstanceAOD 9604 (hGH fragment 176-191)
Dosage5 mg per vial
Package1 lyophilized vial
FormFreeze-dried powder, requires reconstitution
Drug ClassResearch peptide, hGH fragment
ManufacturingGMP-certified
TestingHPLC per batch, COA on file
ShippingU.S. domestic and international

Stacks

AOD 9604 Fasted Course

Five milligrams with 2 ml gives 250 mcg per 10 units, and community material describes a daily dose before fasted cardio in blocks of four to twelve weeks.

Outcome: a fat-mobilization signal that does not touch IGF-1, and no proven clinical benefit.

Two Fat-Loss Peptides Together

A common research pairing adds the vascular-targeting Adipotide 10 mg vial or the incretin Semaglutide.

Outcome: unrelated mechanisms aimed at the same goal, with no combination study and real safety questions.

Compared With The Growth Axis

Users comparing the fragment with a full growth signal often read it next to IGF-1 LR3 1 mg.

Outcome: one peptide built to avoid IGF-1 and one that is its analogue, deliberately different tools.

FAQ

Before you ask

Questions, answered

It is the fragment of human growth hormone that runs from residue 176 to 191, 16 amino acids that carry the fat-mobilizing activity without the growth effects of the whole hormone. In research it did not raise IGF-1, which was the point of separating it. It has no approved use and is sold as research material.

Partly, and then no. A 12-week randomized study reported about 1.8 kg more weight loss than placebo, but a later 24-week study did not show sufficient lipolytic effect and the program was closed in 2007. Anyone quoting a dramatic fat-loss figure is quoting marketing rather than the trial record, and the vial here is research material.

No half-life is established for AOD 9604 in the sources checked, so no timing recommendation can be derived from pharmacokinetics. To mix, run bacteriostatic water down the glass wall and swirl, never shake: 5 mg with 2 ml gives 2.5 mg/ml, so 0.1 ml holds 250 mcg and equals 10 units on a U-100 syringe. Community material describes 250 to 500 mcg daily in short blocks.

The fragment is described with injection-site reactions and headache in trial reports, and it does not carry the growth or glucose effects of whole growth hormone. For testing, the peptide is found in urine by LC-MS/MS at a limit of 50 pg/ml, and growth hormone fragments are named in WADA class S2.2.3, which means a prohibited substance at all times in sport.

The 5 mg vial is listed as research material with U.S. domestic and international shipping, and price and stock appear against the option selector above. Note that clinical work on this fragment used the oral route, while the product here is a lyophilized powder for laboratory handling, so the vial and the trial product are not the same preparation.

No reviews yet

Be the first to share your experience with Dragon Pharma AOD 9604 5 mg hGH Fragment 176-191 Research Vial

Log in to write a review